Key Insights

Highlights

Success Rate

72% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

14.3%

7 terminated out of 49 trials

Success Rate

72.0%

-14.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

4 of 18 completed with results

Key Signals

4 with results72% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (20)
Early P 1 (1)
P 1 (10)
P 2 (4)

Trial Status

Completed18
Recruiting15
Terminated7
Not Yet Recruiting5
Active Not Recruiting2
Unknown2

Trial Success Rate

72.0%

Benchmark: 86.6%

Based on 18 completed trials

Clinical Trials (49)

Showing 20 of 20 trials
NCT06910657Phase 1Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06472726Not ApplicableTerminated

Mental Health App for Cancer Survivors Study

NCT07241273Not ApplicableNot Yet Recruiting

SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer

NCT05787587Phase 1Active Not Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT07462377Phase 1Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT00568490Recruiting

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

NCT07675421Not ApplicableRecruitingPrimary

Impact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer

NCT06896448Not ApplicableRecruiting

Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App

NCT07651020Completed

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

NCT07622914RecruitingPrimary

The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer

NCT04565457Not ApplicableCompleted

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

NCT06676943Not ApplicableCompleted

Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection

NCT02997332Phase 1TerminatedPrimary

Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT06681233Not ApplicableRecruitingPrimary

Feasibility Study of CBCT for IGRT in Cancer Patients

NCT07437326Not Yet Recruiting

Food-related Quality of Life in Patients With Cancer

NCT03556228Phase 1Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT06771336RecruitingPrimary

Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap

NCT05272917Not ApplicableCompletedPrimary

SOMESThesia and ALIMentation

NCT06638216Not ApplicableCompletedPrimary

Prospective Evaluation of Frailty in Patients With Head and Neck Tumors Before Curative Intended Therapy

NCT06940505Not ApplicableRecruitingPrimary

Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care

Scroll to load more

Research Network

Activity Timeline